DE1770478A1 - Gereinigte hypoallergene alpha-Aminopenicilline und Verfahren zu ihrer Gewinnung - Google Patents
Gereinigte hypoallergene alpha-Aminopenicilline und Verfahren zu ihrer GewinnungInfo
- Publication number
- DE1770478A1 DE1770478A1 DE19681770478 DE1770478A DE1770478A1 DE 1770478 A1 DE1770478 A1 DE 1770478A1 DE 19681770478 DE19681770478 DE 19681770478 DE 1770478 A DE1770478 A DE 1770478A DE 1770478 A1 DE1770478 A1 DE 1770478A1
- Authority
- DE
- Germany
- Prior art keywords
- procedure
- purified
- group
- takes place
- high molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 17
- 230000000774 hypoallergenic effect Effects 0.000 title description 5
- 229930182555 Penicillin Natural products 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 11
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 7
- 229940049954 penicillin Drugs 0.000 claims description 7
- 230000000890 antigenic effect Effects 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 238000000108 ultra-filtration Methods 0.000 claims description 2
- 230000017854 proteolysis Effects 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 150000002960 penicillins Chemical class 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 150000004684 trihydrates Chemical class 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 208000024780 Urticaria Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- -1 alkali metal salt Chemical class 0.000 description 2
- 229960003311 ampicillin trihydrate Drugs 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2528867A GB1223843A (en) | 1967-06-01 | 1967-06-01 | PURIFICATION OF alpha-AMINOPENICILLINS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1770478A1 true DE1770478A1 (de) | 1971-11-04 |
Family
ID=10225288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19681770478 Pending DE1770478A1 (de) | 1967-06-01 | 1968-05-22 | Gereinigte hypoallergene alpha-Aminopenicilline und Verfahren zu ihrer Gewinnung |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE715992A (https=) |
| DE (1) | DE1770478A1 (https=) |
| ES (1) | ES354381A1 (https=) |
| FR (1) | FR1590120A (https=) |
| GB (1) | GB1223843A (https=) |
| NL (1) | NL6807084A (https=) |
-
1967
- 1967-06-01 GB GB2528867A patent/GB1223843A/en not_active Expired
-
1968
- 1968-05-17 NL NL6807084A patent/NL6807084A/xx unknown
- 1968-05-22 DE DE19681770478 patent/DE1770478A1/de active Pending
- 1968-05-28 ES ES354381A patent/ES354381A1/es not_active Expired
- 1968-05-31 BE BE715992D patent/BE715992A/xx unknown
- 1968-06-26 FR FR1590120D patent/FR1590120A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1223843A (en) | 1971-03-03 |
| BE715992A (https=) | 1968-12-02 |
| FR1590120A (https=) | 1970-04-13 |
| NL6807084A (https=) | 1968-12-02 |
| ES354381A1 (es) | 1969-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2417619C2 (de) | Intramolekular vernetztes Hämoglobin, Verfahren zu dessen Herstellung und seine Verwendung | |
| DE2126680B2 (de) | Carcinoembryonales Antigen | |
| DE2219635C3 (de) | Insulinsalz-Protamin-Komplexe und Verfahren zu ihrer Herstellung | |
| DE3346336A1 (de) | Verfahren zur herstellung von erythropoetin | |
| CH414063A (de) | Röntgenkontrastmittel | |
| DE2506260A1 (de) | Verfahren zum entfernen pyrogenen materials aus waessrigen loesungen | |
| DE3024282A1 (de) | Vakzinierende glycopeptid-antigenfraktion mit grosser immunisierungsfaehigkeit, isoliert aus kulturen pathogener keime, verfahren zur isolierung dieser fraktion und diese enthaltende vakzinen | |
| DE2355094A1 (de) | Tetanus-vaccine und verfahren zu deren herstellung | |
| DE3221448C2 (https=) | ||
| DE2137011C3 (de) | Verfahren zur Gewinnung reinen Konjakumannans und daraus hergestelltes pharmazeutisches Präparat | |
| CH630643A5 (en) | Process for concentrating a placenta-specific glycoprotein. | |
| DE1770478A1 (de) | Gereinigte hypoallergene alpha-Aminopenicilline und Verfahren zu ihrer Gewinnung | |
| DE2513848A1 (de) | Verfahren zur gewinnung ununterbrochener staemme von tumorzellen in vitro | |
| DE3249251C2 (de) | Therapeutische Mittel zur Behandlung von allergischen St¦rungen, Immunkomplexerkrankungen und Tumoren | |
| AT224807B (de) | Verfahren zur Gewinnung eines neuen tumorhemmenden Polysaccharids | |
| CH652028A5 (de) | Extrakt aus pflanzen vom genus epimedium sp., verfahren zur herstellung dieses extrakts und verwendung des extrakts als wirksame komponente in einem immunstimulierenden mittel. | |
| DE1958329C3 (de) | Verfahren zur Reinigung von Cephaloglycin | |
| US2256933A (en) | Process for obtaining a substance lowering the blood pressure | |
| DE2333884A1 (de) | Verfahren zur herstellung von gereinigtem albumin und das dabei erhaltene gereinigte albumin | |
| CH660125A5 (de) | Gereinigtes, entgiftetes endotoxin enthaltende zusammensetzung. | |
| DE1667929A1 (de) | Vakzine | |
| DE3319360A1 (de) | Pepsinartiges human-leukozyten-enzym, verfahren zur herstellung des enzyms und therapeutische zusammensetzung, welches dasselbe als wirkstoff enthaelt, sowie verwendung der zusammensetzung zur bekaempfung allergischer stoerungen, immunkomplex-erkrankungen und von tumoren | |
| US2124951A (en) | Method of concentrating serum | |
| Griffith | A study of the serological reactions of meningococci and an account of the method of preparation of anti-meningococcus serum | |
| DE681024C (de) | Verfahren zur schonenden Gewinnung loeslicher Vollantigene aus Mikroorganismen |